Trial intelligence / Profile preview

Simvastatin effects on neutrophil function in healthy elderly subjects

2011-002082-38Phase 4Completed

Sponsor
University of Birmingham
Start
Jan 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of simvastatin, sponsored by University of Birmingham. Primary endpoints: Neutrophil adhesion, chemokinesis and chemotaxis, Cell surface receptor expression and 3 more. Started Jan 2012; status: completed.

02

Drugs

simvastatin

Beyond the preview

Go deeper on 2011-002082-38.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-002082-38.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call